Get informed when a big investor buys or sells
+ FollowOvervalued by 109.4% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $53.87 Million |
|---|---|
| Enterprise Value | $55.24 Million |
| Earnings per Share | $-0.34 |
| Beta | 0.14 |
| Outstanding Shares | 32,922,413 |
| P/E Ratio | -5.34 |
|---|---|
| PEG | 77.5 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 126.55 |
| Enterprise Value to EBIT | -5.53 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | -5.99 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Positron Corporation is a healthcare firm specializing in nuclear medicine, with a core emphasis on cardiac Positron Emission Tomography (PET) imaging services throughout the United States. The company empowers healthcare providers by of...